US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,017 | -2,812 | -1,707 | -947 | -4,697 |
| Depreciation Amortization | 579 | 108 | 104 | 56 | 1,203 |
| Accounts receivable | 2 | 2 | 3 | 4 | -4 |
| Accounts payable and accrued liabilities | 324 | 273 | 223 | 254 | 301 |
| Other Working Capital | 1,827 | 1,197 | 669 | 508 | 960 |
| Other Operating Activity | 188 | 327 | 154 | 41 | 542 |
| Operating Cash Flow | $-1,095 | $-905 | $-554 | $-84 | $-1,694 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -1 | -1 | N/A | N/A |
| Investing Cash Flow | $-1 | $-1 | $-1 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 475 | 415 | 174 | 0 | 558 |
| Common Stock Issued | 585 | 460 | 379 | 118 | 1,426 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -257 |
| Financing Cash Flow | $1,059 | $874 | $553 | $118 | $1,727 |
| Beginning Cash Position | 37 | 37 | 37 | 37 | 3 |
| End Cash Position | N/A | 5 | 35 | 70 | 37 |
| Net Cash Flow | $-37 | $-32 | $-2 | $33 | $34 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,095 | -905 | -554 | -84 | -1,694 |
| Capital Expenditure | -1 | -1 | -1 | 0 | N/A |
| Free Cash Flow | -1,096 | -906 | -554 | -84 | -1,694 |